Clinical Trials Browser

Phase 1 × zanidatamab × 1 year × Clear all

NCT05868226 2025-04-04

PRE-I-SPY-PI

Phase 1 Recruiting

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms